Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 SEK | -8.22% | -4.14% | -17.87% |
08:30am | Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 27 | Enzymatica AB Announces Composition of Nomination Committee | CI |
Sales 2024 * | 7.14M 77.8M | Sales 2025 * | 13.98M 152M | Capitalization | 56.2M 612M |
---|---|---|---|---|---|
Net income 2024 * | -3M -32.69M | Net income 2025 * | - 0 | EV / Sales 2024 * | 8.15 x |
Net Debt 2024 * | 2.01M 21.88M | Net cash position 2025 * | 2.05M 22.36M | EV / Sales 2025 * | 3.87 x |
P/E ratio 2024 * |
-19.1
x | P/E ratio 2025 * |
-40.5
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 36.72% |
1 day | -8.22% | ||
1 week | -4.14% | ||
Current month | -0.31% | ||
1 month | +6.23% | ||
3 months | -3.28% | ||
6 months | -22.77% | ||
Current year | -17.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ulf Thomas Blom
FOU | Founder | 59 | 06-12-31 |
Claus Egstrand
CEO | Chief Executive Officer | 63 | 17-07-17 |
Director of Finance/CFO | 55 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bengt Baron
CHM | Chairman | 62 | 16-12-18 |
Director/Board Member | 56 | 16-02-14 | |
Director/Board Member | 57 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.24 | -8.22% | 96 511 |
24-04-24 | 3.53 | +2.62% | 12,555 |
24-04-23 | 3.44 | -0.29% | 23,983 |
24-04-22 | 3.45 | +1.77% | 66,198 |
24-04-19 | 3.39 | +0.30% | 47,573 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:11 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.87% | 56.2M | |
+24.17% | 562B | |
-6.23% | 358B | |
+20.04% | 322B | |
+8.01% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.51% | 149B | |
-6.37% | 146B |
- Stock Market
- Equities
- ENZY Stock